- Home
- GOVX vs SBFM Comparison
GOVX vs SBFM Comparison
Compare GOVX & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- SBFM
- Stock Information
- Founded
- GOVX 2001
- SBFM 2006
- Country
- GOVX United States
- SBFM United States
- Employees
- GOVX N/A
- SBFM N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- GOVX Health Care
- SBFM Health Care
- Exchange
- GOVX Nasdaq
- SBFM Nasdaq
- Market Cap
- GOVX 7.6M
- SBFM 6.7M
- IPO Year
- GOVX N/A
- SBFM N/A
- Fundamental
- Price
- GOVX $0.75
- SBFM $1.56
- Analyst Decision
- GOVX Strong Buy
- SBFM Strong Buy
- Analyst Count
- GOVX 4
- SBFM 1
- Target Price
- GOVX $10.50
- SBFM $15.00
- AVG Volume (30 Days)
- GOVX 2.7M
- SBFM 189.5K
- Earning Date
- GOVX 08-05-2025
- SBFM 08-15-2025
- Dividend Yield
- GOVX N/A
- SBFM N/A
- EPS Growth
- GOVX N/A
- SBFM N/A
- EPS
- GOVX N/A
- SBFM N/A
- Revenue
- GOVX $5,591,576.00
- SBFM $36,234,578.00
- Revenue This Year
- GOVX N/A
- SBFM $32.20
- Revenue Next Year
- GOVX N/A
- SBFM $32.74
- P/E Ratio
- GOVX N/A
- SBFM N/A
- Revenue Growth
- GOVX N/A
- SBFM 35.51
- 52 Week Low
- GOVX $0.43
- SBFM $1.17
- 52 Week High
- GOVX $11.18
- SBFM $6.99
- Technical
- Relative Strength Index (RSI)
- GOVX 47.67
- SBFM 52.23
- Support Level
- GOVX $0.60
- SBFM $1.42
- Resistance Level
- GOVX $0.76
- SBFM $1.56
- Average True Range (ATR)
- GOVX 0.08
- SBFM 0.10
- MACD
- GOVX 0.02
- SBFM 0.00
- Stochastic Oscillator
- GOVX 59.45
- SBFM 39.39
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.